Peter E. Boyd - 09 Mar 2024 Form 4 Insider Report for Aquestive Therapeutics, Inc. (AQST)

Reporting relationship: SVP, Information Technology, Human Resources and Communications
Issuer ticker: AQST
Reported as of: 09 Mar 2024
Net transaction value: -$40,846
SEC form: 4
Accepted by SEC: 12 Mar 2024, 13:47:29 UTC
Prior SEC filing: 11 Mar 2024
Next SEC filing: 13 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Lori Braender, as Attorney-In-Fact

Key filing fact

Peter E. Boyd filed Form 4 for Aquestive Therapeutics, Inc. (AQST) on 12 Mar 2024.

Key facts

This page summarizes Peter E. Boyd's Form 4 filing for Aquestive Therapeutics, Inc. (AQST).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 12 Mar 2024, 13:47.

Change

Previous filing in this sequence was filed on 11 Mar 2024.
Current net transaction value: -$40,846.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AQST transaction

Common Stock

Tax liability

Transaction value: $40,846
Shares: -8,370
Change %: -3.4%
Price: $4.88
Shares after: 237,628
Date: 09 Mar 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.

SEC remarks

SVP, Information Technology, Human Resources and Communications